MET and colonic neoplasm: We applied a limited candidate gene approach (EGFR, HGF ad MET by immunohistochemistry), array CGH, and genomic sequencing to compare CB42 to other propagation-incapable, β-Catenin-driven primary colon tumors to identify a series of candidate genes that correlated with propagation/metastasis.